Published on September 15, 2015 by

The effect of sexually transmitted co-infections on HIV viral load among individuals on antiretroviral therapy

Antiretroviral therapy (ART) markedly reduces the risk of sexual transmission of HIV. This inspired the idea of treatment as prevention (TasP) to reduce population HIV incidence, by reducing the infectiousness of HIV-infected individuals. However, increased infectiousness when treated individuals are co-infected with other sexually transmitted infections (STIs) could potentially undercut the effectiveness of TasP programs. As there is limited knowledge about the impact of STI co-infections on HIV shedding from individuals on ART, this study reviewed all published scientific evidence.